arrow
G

Gabriele Ihorst

University of Freiburg
H指数:53
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Extracorporeal photopheresis for the treatment of steroid-refractory immune related adverse events from immune checkpoint inhibitor therapy: a multi-center phase Ib/II clinical trial

体外光opheresis治疗免疫检查点抑制剂疗法所致的类固醇难治性免疫相关不良反应:一项多中心Ib/II期临床试验

2026-10-230
OAAI
ABACHAI - Safety and efficacy of abatacept (s.c.) in patients with CTLA4 insufficiency or LRBA deficiency, a phase II clinical trial

ABACHAI - 阿巴西特(皮下注射)在CTLA4缺乏或LRBA缺陷患者中的安全性与有效性,一项II期临床试验

2026-09-190
OAAI
Effect of geriatric co-management on independence, quality of life, and severe toxicity in vulnerable older patients with cancer: Results of a randomized clinical trial

老年共管对脆弱癌症患者独立性、生活质量及严重毒性的影响:一项随机临床试验的结果

2026-02-040
OAAI
Role of Geriatric Assessment Scores as Predictors of Intensive Therapy Feasibility and Survival in Elderly Patients with Primary CNS Lymphoma

老年评估评分作为老年原发性中枢神经系统淋巴瘤患者强化疗可行性和生存的预测指标的作用

2025-11-250
OAAI
Analysis of skeletal pain, general symptoms and patient-reported outcome measures and their value in detecting symptomatic progression – An interdisciplinary prospective study in patients with multiple myeloma

骨骼疼痛、一般症状及患者报告结局指标的分析及其在检测症状性进展中的价值——一项针对多发性骨髓瘤患者的跨学科前瞻性研究

2025-06-010
OA
Teduglutide for treatment-refractory severe intestinal acute graft-versus-host disease - a multicenter survey

Teduglutide治疗难治性严重肠道急性移植物抗宿主病——一项多中心调查

2025-04-140
OA
High-dose chemotherapy and autologous haematopoietic stem-cell transplantation in older, fit patients with primary diffuse large B-cell CNS lymphoma (MARTA): a single-arm, phase 2 trial
2024-03-016
PRE
Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients - the randomized phase III PRIMA-CNS trial
2023-08-185
OAAI